Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data.
A novel progestogen, drospirenone, in combination with 17beta-estradiol has been studied as hormone therapy (HT) for menopausal symptoms. In addition to providing effective and safe relief of menopausal symptoms, the combination has a beneficial effect on blood pressure and weight gain.
Archer
David F
DF
Department of Obstetrics and Gynecology and CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia, USA. archerdf@evms.edu
D000736:Androstenes / Q000494:pharmacology*; D001842:Bone and Bones / Q000187:drug effects; D004338:Drug Combinations; D004958:Estradiol / Q000494:pharmacology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D008593:Menopause / Q000187:drug effects*; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology*
D000736:Androstenes; D004338:Drug Combinations; D000451:Mineralocorticoid Receptor Antagonists; D004958:Estradiol; C035144:drospirenone